| 发明名称 |
TARGETING THE EGFR-SGLT1 INTERACTION FOR CANCER THERAPY |
| 摘要 |
A compound can destabilize a binding interaction between an epidermal growth factor receptor (EGFR) and a sodium/glucose co-transporter 1 (SGLT 1). In one embodiment, the compound is a peptide derived from the interacting domain of EGFR. In another embodiment, the peptide is administered to a patient to treat cancer. |
| 申请公布号 |
EP2994155(A2) |
申请公布日期 |
2016.03.16 |
| 申请号 |
EP20140794114 |
申请日期 |
2014.05.08 |
| 申请人 |
THE UNIVERSITY OF HOUSTON SYSTEM |
发明人 |
WEIHUA, ZHANG |
| 分类号 |
A61K38/10;A61K31/70;A61P35/00;C07K7/08;C07K14/00 |
主分类号 |
A61K38/10 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
